Remedy Biologics is a nano-scale biotechnology company based in Dublin. Their mission is to create new therapies for the world's most challenging diseases by mapping the function of cells directly from patient biology. They leverage the power of the human immune system to cure diseases.

The leadership team at Remedy Biologics consists of experienced individuals who are dedicated to transforming the field of biotechnology. CEO and Co-Founder Dan Crowley is focused on strategic leadership and building transformational partnerships with industry leaders. President and CSO Dr.

Rick Leach has built expertise in genomics, big data, reproductive medicine, and corporate strategy. CTO and Co-Founder Paul Leonard leads the scientific aspects of the company with his diverse technical team. CMO and Co-Founder Colm Galligan works on translating the technology's potential into patient-centered outcomes.

Remedy Biologics also has a strong team of individuals working in business development and operations, ensuring the successful growth and operations of the company. Furthermore, the company benefits from the expertise of the Scientific Advisory Board, which includes pharmaceutical R&D leaders with extensive experience in genomics and target discovery. With their cutting-edge technology and team of experts, Remedy Biologics is committed to revolutionizing the field of biotechnology and discovering new therapies through a deep understanding of the immune system